Digital coaching program for severe asthma control
Part of Immune system & allergy, Lungs & breathing clinical trials.
This Phase 3 study tests whether an asthma care program with digital (phone-based) support helps people with severe asthma stay more stable and manage symptoms better. You may need to meet specific criteria for “severe, refractory” asthma and be willing to use a smartphone for monitoring and coaching.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed asthma diagnosis based on guideline tests (like breathing test reversibility, FeNO, or a provocation test).
- Your asthma is considered severe and hard to control, and your care team says you are eligible for a specific asthma biologic (omalizumab, mepolizumab, benralizumab, reslizumab, or dupilumab).
- If you were previously on an asthma biologic, it must be stopped for at least 4 times that medicine’s “half-life.”
- Your asthma has been relatively stable for at least 4 weeks (no recent flare-up and no recent respiratory infection).
- You can and will use a smartphone for remote monitoring and coaching, and you can read and understand Dutch; you also need to be able to do physical activity.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to monitor severe asthma that is driven by high levels of inflammation (T2-high). It involves a bronchoscopy (a thin tube to look inside your lungs) to see how well the treatment is working.
This study tests a new way to treat asthma flares in children and teens (ages 6–18) with mild-to-moderate asthma. It aims to see if a quick-relief anti-inflammatory medicine works better than current treatments to prevent severe attacks.
This study tests a program that combines exercise, lifestyle advice, and support to help people with difficult-to-control asthma who are not very active. The goal is to see if this program can improve your overall health and asthma control.
This study tests if using a small smart device with your Trimbow inhaler helps you use it correctly and take it as prescribed. It is for people with asthma who already use Trimbow.
This trial tests whether stepping up to either a higher dose of inhaled steroid/long-acting bronchodilator or a special fine-particle triple therapy (which includes an extra medication) can improve small-airway health in people whose asthma is still not well controlled on a medium-dose combination.
This trial looks at people with severe asthma that is hard to control. It aims to find and treat specific health problems that make asthma worse, by doing a detailed check-up and using treatments that are right for you.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.